Amdocs Stock Forecast, Price & News

Amdocs' stock was trading at $61.42 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, DOX stock has increased by 14.0% and is now trading at $70.02.
View which stocks have been most impacted by COVID-19.

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Amdocs stock.
View analyst ratings for Amdocs or view MarketBeat's top 5 stock picks.

Wall Street analysts have given Amdocs a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Amdocs wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Amdocs is scheduled to release its next quarterly earnings announcement on Tuesday, February 2nd 2021.
View our earnings forecast for Amdocs.

Amdocs will be holding an earnings conference call on Tuesday, February 2nd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Amdocs Limited (NASDAQ:DOX) posted its quarterly earnings data on Tuesday, November, 10th. The technology company reported $1.23 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.19 by $0.04. The technology company had revenue of $1.05 billion for the quarter, compared to analysts' expectations of $1.03 billion. Amdocs had a net margin of 11.94% and a return on equity of 15.57%. Amdocs's revenue was up 2.2% compared to the same quarter last year. During the same period last year, the company earned $1.08 earnings per share.
View Amdocs' earnings history.

Amdocs announced a quarterly dividend on Tuesday, November 10th. Investors of record on Thursday, December 31st will be given a dividend of $0.327 per share on Friday, January 22nd. This represents a $1.31 annualized dividend and a yield of 1.87%. The ex-dividend date is Wednesday, December 30th.
View Amdocs' dividend history.

Amdocs pays an annual dividend of $1.31 per share and currently has a dividend yield of 1.87%. Amdocs has been increasing its dividend for 7 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio of Amdocs is 31.26%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Amdocs will have a dividend payout ratio of 27.52% next year. This indicates that Amdocs will be able to sustain or increase its dividend.
View Amdocs' dividend history.

Amdocs updated its first quarter earnings guidance on Tuesday, November, 10th. The company provided EPS guidance of $1.09-1.15 for the period, compared to the Thomson Reuters consensus estimate of $1.14. The company issued revenue guidance of $1.055-1.095 billion, compared to the consensus revenue estimate of $1.06 billion.

4 Wall Street analysts have issued twelve-month price objectives for Amdocs' stock. Their forecasts range from $74.00 to $76.00. On average, they anticipate Amdocs' share price to reach $75.00 in the next year. This suggests a possible upside of 7.1% from the stock's current price.
View analysts' price targets for Amdocs or view Wall Street analyst' top-rated stocks.

Amdocs saw a decline in short interest during the month of December. As of December 31st, there was short interest totaling 2,170,000 shares, a decline of 15.9% from the December 15th total of 2,580,000 shares. Based on an average daily trading volume, of 665,900 shares, the short-interest ratio is presently 3.3 days. Approximately 1.7% of the company's shares are sold short.
View Amdocs' Short Interest.

Some companies that are related to Amdocs include Accenture (ACN), International Business Machines (IBM), Cognizant Technology Solutions (CTSH), EPAM Systems (EPAM), Leidos (LDOS), Gartner (IT), Booz Allen Hamilton (BAH), CACI International (CACI), ManTech International (MANT), Teradata (TDC), Virtusa (VRTU), Unisys (UIS), Forrester Research (FORR), The Hackett Group (HCKT) and ServiceSource International (SREV).
View all of DOX's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include The Home Depot (HD), Pfizer (PFE), AT&T (T), NVIDIA (NVDA), Exxon Mobil (XOM), AbbVie (ABBV), International Business Machines (IBM), Johnson & Johnson (JNJ), Advanced Micro Devices (AMD) and Comcast (CMCSA).

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

Amdocs' stock is owned by a number of retail and institutional investors. Top institutional investors include Crossmark Global Holdings Inc. (0.08%), State of Alaska Department of Revenue (0.07%), HGK Asset Management Inc. (0.05%), Bowling Portfolio Management LLC (0.02%), Donald L. Hagan LLC (0.01%) and Orrstown Financial Services Inc. (0.01%).

DOX stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Crossmark Global Holdings Inc., Bowling Portfolio Management LLC, and Sowell Financial Services LLC.

DOX stock was purchased by a variety of institutional investors in the last quarter, including Raymond James Trust N.A., HGK Asset Management Inc., Diversified Trust Co, Donald L. Hagan LLC, Orrstown Financial Services Inc., OneAscent Financial Services LLC, and Wedge Capital Management L L P NC.

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of DOX stock can currently be purchased for approximately $70.02.

Amdocs has a market capitalization of $9.18 billion and generates $4.17 billion in revenue each year. The technology company earns $497.84 million in net income (profit) each year or $4.19 on an earnings per share basis. Amdocs employs 25,875 workers across the globe.

The official website for Amdocs is www.amdocs.com.

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at 1 314 212 7000 or via email at [email protected]